文献速递主动脉疾病

定制开窗支架与医生改良支架治疗复杂主动脉瘤的术中不良事件与早期结局

Intraoperative adverse events and early outcomes of custom-made fenestrated stent grafts and physician-modified stent grafts for complex aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2019-11-07

PMSG组ASA 4级和TAAA比例更高,两组术中不良事件、院内死亡、术后并发症、再干预率存在差异,慢性肾衰竭是术后死亡或并发症的独立危险因素。PMSG在紧急情况下可接受。

要点

  • PMSG在无法或不宜使用CMSG的紧急干预中可提供可接受的院内结果。

核心结论

  • CMSG与PMSG组在多个重要院内结局上存在临床相关差异,需更大样本和更长随访直接比较。
  • PMSG在需要紧急干预且CMSG不可用或不可行时可能提供可接受的院内结果。

研究设计与样本

  • CMSG组69例,PMSG组28例。

主要发现

  • 术中不良事件:CMSG组8例(11%),PMSG组6例(21%);无术中死亡或中转开放手术。
  • 院内死亡:CMSG组4%(3例),PMSG组14%(4例)。
  • 术后并发症:CMSG组22%(15例),PMSG组25%(7例);脊髓缺血:CMSG组4%(3例),PMSG组7%(2例)。
  • 再干预:CMSG组16%(11例),PMSG组32%(9例)。
  • 出院时靶血管通畅率:CMSG组98%(207/210),PMSG组全部98根靶血管通畅;内漏:CMSG组24%(16例),PMSG组8%(2例)。

临床怎么用

  • 在紧急或半紧急情况下,当CMSG不可用或不可行时,PMSG可作为治疗CAAA或TAAA的选择。
  • 术前应评估慢性肾衰竭,其与术后死亡或并发症风险独立相关。

局限性

  • 两组基线特征存在显著差异(PMSG组ASA 4级和TAAA比例更高),可能影响结局比较。
  • 需要更大样本和更长随访以直接比较CMSG与PMSG。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Physician-modified fenestrated stent grafts (PMSGs) are a useful option for urgent or semiurgent treatment of complex abdominal aortic aneurysms (CAAAs). The aim of this study was to describe in-hospital outcomes of custom-made fenestrated stent grafts (CMSGs) and PMSGs for the treatment of CAAAs and thoracoabdominal aortic aneurysms (TAAAs). METHODS: In this single-center, retrospective study, all consecutives patients with CAAAs or TAAAs undergoing endovascular repair using Zenith CMSGs (Cook Medical, Bloomington, Ind) or PMSGs between January 2012 and November 2017 were included. End points were intraoperative adverse events, in-hospital mortality, postoperative complications, reinterventions, target vessel patency, and endoleaks. RESULTS: Ninety-seven patients were included (CMSGs, n = 69; PMSGs, n = 28). The PMSG group included more patients assigned to American Society of Anesthesiologists class 4 (n = 14 [50%] vs n = 16 [23%]; P = .006) and more TAAAs (n = 17 [61%] vs n = 10 [15%]; P < .0001). Intraoperative adverse events were recorded in eight (11%) patients in the CMSG group vs six (21%) patients in the PMSG group. No intraoperative death or open conversion occurred. In-hospital mortality rates were of 4% (n = 3) in the CMSG group and 14% in the PMSG group (n = 4). Chronic renal failure was an independent preoperative risk factor of postoperative death or complications (odds ratio, 4.88; 95% confidence interval, 1.65-14.43; P = .004). Rates of postoperative complications were 22% (n = 15) and 25% (n = 7) in the CMSG and PMSG groups. Spinal cord ischemia rates were 4% (n = 3) and 7% (n = 2) in the CMSG and PMSG groups. Reintervention rates were 16% (n = 11) in the CMSG group and 32% (n = 9) in the PMSG group. At discharge, target vessel patency rate in CMSGs was 98% (n = 207/210). All target vessels (n = 98) were patent in the PMSG group. Endoleaks at discharge were observed in 24% of the CMSG group (n = 16) vs 8% of the PMSG group (n = 2). CONCLUSIONS: Our study showed clinically relevant differences of several important in-hospital outcomes in the CMSG and PMSG groups. Larger cohorts and longer follow-up are needed to allow direct comparison. PMSGs may offer acceptable in-hospital results in patients requiring urgent interventions when CMSGs are not available or possible.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sénémaud JN, Ben Abdallah I, de Boissieu P, et al. Intraoperative adverse events and early outcomes of custom-made fenestrated stent grafts and physician-modified stent grafts for complex aortic aneurysms. J Vasc Surg. 2019. PMID: 31708298. doi:10.1016/j.jvs.2019.07.102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。